Global Hiv Drugs Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	164 Pages	TechNavio	July, 2024	INF19033883

Best Price Guarantee
Price	from $2,500
Length	164 Pages
Publisher	TechNavio
Published Date	July, 2024
SKU	INF19033883

Global Hiv Drugs Market 2024-2028

The hiv drugs market is forecasted to grow by USD 9.99 bn during 2023-2028, accelerating at a CAGR of 5.02% during the forecast period. The report on the hiv drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of hiv aids worldwide, increasing cases of associated risk factors, and surge in geriatric population.

Technavio's hiv drugs market is segmented as below:

By Distribution Channel

Offline
Online

By Therapy

Combination HIV medicines
Integrase inhibitors
Non-nucleoside reverse transcriptase inhibitors
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the expanding access to hiv treatment as one of the prime reasons driving the hiv drugs market growth during the next few years. Also, rising demand for targeted therapies and advances in diagnostics of hiv virus will lead to sizable demand in the market.

The report on the hiv drugs market covers the following areas:

Hiv drugs market sizing
Hiv drugs market forecast
Hiv drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hiv drugs market vendors that include AbbVie Inc., Aspen Pharmacare Holdings Ltd., Aurobindo Pharma Ltd., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Cadila Pharmaceuticals Ltd., Cipla Inc., Emcure Pharmaceuticals Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Hetero Labs Ltd., Johnson and Johnson Services Inc., Lupin Ltd., Macleods Pharmaceuticals Ltd., Merck and Co. Inc., Strides Pharma Science Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., and Viatris Inc.. Also, the hiv drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Distribution Channel; Executive Summary - Chart on Market Segmentation by Therapy; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ billion); Data Table on Global - Market size and forecast 2023-2028 ($ billion); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global HIV Drugs Market 2018 - 2022; Historic Market Size - Data Table on Global HIV Drugs Market 2018 - 2022 ($ billion); 4.2 Distribution Channel segment analysis 2018 - 2022; Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion); 4.3 Therapy segment analysis 2018 - 2022; Historic Market Size - Therapy Segment 2018 - 2022 ($ billion); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ billion); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Distribution Channel: 6.1 Market segments; Chart on Distribution Channel - Market share 2023-2028 (%); Data Table on Distribution Channel - Market share 2023-2028 (%); 6.2 Comparison by Distribution Channel; Chart on Comparison by Distribution Channel; Data Table on Comparison by Distribution Channel; 6.3 Offline - Market size and forecast 2023-2028; Chart on Offline - Market size and forecast 2023-2028 ($ billion); Data Table on Offline - Market size and forecast 2023-2028 ($ billion); Chart on Offline - Year-over-year growth 2023-2028 (%); Data Table on Offline - Year-over-year growth 2023-2028 (%); 6.4 Online - Market size and forecast 2023-2028; Chart on Online - Market size and forecast 2023-2028 ($ billion); Data Table on Online - Market size and forecast 2023-2028 ($ billion); Chart on Online - Year-over-year growth 2023-2028 (%); Data Table on Online - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by Distribution Channel; Market opportunity by Distribution Channel ($ billion); Data Table on Market opportunity by Distribution Channel ($ billion)
7 Market Segmentation by Therapy: 7.1 Market segments; Chart on Therapy - Market share 2023-2028 (%); Data Table on Therapy - Market share 2023-2028 (%); 7.2 Comparison by Therapy; Chart on Comparison by Therapy; Data Table on Comparison by Therapy; 7.3 Combination HIV medicines - Market size and forecast 2023-2028; Chart on Combination HIV medicines - Market size and forecast 2023-2028 ($ billion); Data Table on Combination HIV medicines - Market size and forecast 2023-2028 ($ billion); Chart on Combination HIV medicines - Year-over-year growth 2023-2028 (%); Data Table on Combination HIV medicines - Year-over-year growth 2023-2028 (%); 7.4 Integrase inhibitors - Market size and forecast 2023-2028; Chart on Integrase inhibitors - Market size and forecast 2023-2028 ($ billion); Data Table on Integrase inhibitors - Market size and forecast 2023-2028 ($ billion); Chart on Integrase inhibitors - Year-over-year growth 2023-2028 (%); Data Table on Integrase inhibitors - Year-over-year growth 2023-2028 (%); 7.5 Non-nucleoside reverse transcriptase inhibitors - Market size and forecast 2023-2028; Chart on Non-nucleoside reverse transcriptase inhibitors - Market size and forecast 2023-2028 ($ billion); Data Table on Non-nucleoside reverse transcriptase inhibitors - Market size and forecast 2023-2028 ($ billion); Chart on Non-nucleoside reverse transcriptase inhibitors - Year-over-year growth 2023-2028 (%); Data Table on Non-nucleoside reverse transcriptase inhibitors - Year-over-year growth 2023-2028 (%); 7.6 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ billion); Data Table on Others - Market size and forecast 2023-2028 ($ billion); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 7.7 Market opportunity by Therapy; Market opportunity by Therapy ($ billion); Data Table on Market opportunity by Therapy ($ billion)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ billion); Data Table on North America - Market size and forecast 2023-2028 ($ billion); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ billion); Data Table on Europe - Market size and forecast 2023-2028 ($ billion); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ billion); Data Table on Asia - Market size and forecast 2023-2028 ($ billion); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ billion); Data Table on US - Market size and forecast 2023-2028 ($ billion); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ billion); Data Table on Germany - Market size and forecast 2023-2028 ($ billion); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.9 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ billion); Data Table on China - Market size and forecast 2023-2028 ($ billion); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.10 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ billion); Data Table on UK - Market size and forecast 2023-2028 ($ billion); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.11 Canada - Market size and forecast 2023-2028; Chart on Canada - Market size and forecast 2023-2028 ($ billion); Data Table on Canada - Market size and forecast 2023-2028 ($ billion); Chart on Canada - Year-over-year growth 2023-2028 (%); Data Table on Canada - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ billion); Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 AbbVie Inc.; AbbVie Inc. - Overview; AbbVie Inc. - Product / Service; AbbVie Inc. - Key news; AbbVie Inc. - Key offerings; 12.4 Aurobindo Pharma Ltd.; Aurobindo Pharma Ltd. - Overview; Aurobindo Pharma Ltd. - Product / Service; Aurobindo Pharma Ltd. - Key offerings; 12.5 Bristol Myers Squibb Co.; Bristol Myers Squibb Co. - Overview; Bristol Myers Squibb Co. - Product / Service; Bristol Myers Squibb Co. - Key news; Bristol Myers Squibb Co. - Key offerings; 12.6 Cadila Pharmaceuticals Ltd.; Cadila Pharmaceuticals Ltd. - Overview; Cadila Pharmaceuticals Ltd. - Product / Service; Cadila Pharmaceuticals Ltd. - Key offerings; 12.7 Cipla Inc.; Cipla Inc. - Overview; Cipla Inc. - Business segments; Cipla Inc. - Key news; Cipla Inc. - Key offerings; Cipla Inc. - Segment focus; 12.8 Emcure Pharmaceuticals Ltd.; Emcure Pharmaceuticals Ltd. - Overview; Emcure Pharmaceuticals Ltd. - Product / Service; Emcure Pharmaceuticals Ltd. - Key offerings; 12.9 Gilead Sciences Inc.; Gilead Sciences Inc. - Overview; Gilead Sciences Inc. - Product / Service; Gilead Sciences Inc. - Key news; Gilead Sciences Inc. - Key offerings; 12.10 GlaxoSmithKline Plc; GlaxoSmithKline Plc - Overview; GlaxoSmithKline Plc - Business segments; GlaxoSmithKline Plc - Key news; GlaxoSmithKline Plc - Key offerings; GlaxoSmithKline Plc - Segment focus; 12.11 Hetero Labs Ltd.; Hetero Labs Ltd. - Overview; Hetero Labs Ltd. - Product / Service; Hetero Labs Ltd. - Key offerings; 12.12 Johnson and Johnson Services Inc.; Johnson and Johnson Services Inc. - Overview; Johnson and Johnson Services Inc. - Business segments; Johnson and Johnson Services Inc. - Key news; Johnson and Johnson Services Inc. - Key offerings; Johnson and Johnson Services Inc. - Segment focus; 12.13 Lupin Ltd.; Lupin Ltd. - Overview; Lupin Ltd. - Product / Service; Lupin Ltd. - Key news; Lupin Ltd. - Key offerings; 12.14 Merck and Co. Inc.; Merck and Co. Inc. - Overview; Merck and Co. Inc. - Business segments; Merck and Co. Inc. - Key news; Merck and Co. Inc. - Key offerings; Merck and Co. Inc. - Segment focus; 12.15 Sun Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd. - Overview; Sun Pharmaceutical Industries Ltd. - Product / Service; Sun Pharmaceutical Industries Ltd. - Key news; Sun Pharmaceutical Industries Ltd. - Key offerings; 12.16 Teva Pharmaceutical Industries Ltd.; Teva Pharmaceutical Industries Ltd. - Overview; Teva Pharmaceutical Industries Ltd. - Business segments; Teva Pharmaceutical Industries Ltd. - Key news; Teva Pharmaceutical Industries Ltd. - Key offerings; Teva Pharmaceutical Industries Ltd. - Segment focus; 12.17 Viatris Inc.; Viatris Inc. - Overview; Viatris Inc. - Business segments; Viatris Inc. - Key news; Viatris Inc. - Key offerings; Viatris Inc. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibits6: Executive Summary - Chart on Market Segmentation by Therapy; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ billion); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ billion); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global HIV Drugs Market 2018 - 2022 ($ billion); Exhibits21: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion); Exhibits22: Historic Market Size - Therapy Segment 2018 - 2022 ($ billion); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ billion); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ billion); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on Distribution Channel - Market share 2023-2028 (%); Exhibits33: Data Table on Distribution Channel - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by Distribution Channel; Exhibits35: Data Table on Comparison by Distribution Channel; Exhibits36: Chart on Offline - Market size and forecast 2023-2028 ($ billion); Exhibits37: Data Table on Offline - Market size and forecast 2023-2028 ($ billion); Exhibits38: Chart on Offline - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Offline - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Online - Market size and forecast 2023-2028 ($ billion); Exhibits41: Data Table on Online - Market size and forecast 2023-2028 ($ billion); Exhibits42: Chart on Online - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Online - Year-over-year growth 2023-2028 (%); Exhibits44: Market opportunity by Distribution Channel ($ billion); Exhibits45: Data Table on Market opportunity by Distribution Channel ($ billion); Exhibits46: Chart on Therapy - Market share 2023-2028 (%); Exhibits47: Data Table on Therapy - Market share 2023-2028 (%); Exhibits48: Chart on Comparison by Therapy; Exhibits49: Data Table on Comparison by Therapy; Exhibits50: Chart on Combination HIV medicines - Market size and forecast 2023-2028 ($ billion); Exhibits51: Data Table on Combination HIV medicines - Market size and forecast 2023-2028 ($ billion); Exhibits52: Chart on Combination HIV medicines - Year-over-year growth 2023-2028 (%); Exhibits53: Data Table on Combination HIV medicines - Year-over-year growth 2023-2028 (%); Exhibits54: Chart on Integrase inhibitors - Market size and forecast 2023-2028 ($ billion); Exhibits55: Data Table on Integrase inhibitors - Market size and forecast 2023-2028 ($ billion); Exhibits56: Chart on Integrase inhibitors - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Integrase inhibitors - Year-over-year growth 2023-2028 (%); Exhibits58: Chart on Non-nucleoside reverse transcriptase inhibitors - Market size and forecast 2023-2028 ($ billion); Exhibits59: Data Table on Non-nucleoside reverse transcriptase inhibitors - Market size and forecast 2023-2028 ($ billion); Exhibits60: Chart on Non-nucleoside reverse transcriptase inhibitors - Year-over-year growth 2023-2028 (%); Exhibits61: Data Table on Non-nucleoside reverse transcriptase inhibitors - Year-over-year growth 2023-2028 (%); Exhibits62: Chart on Others - Market size and forecast 2023-2028 ($ billion); Exhibits63: Data Table on Others - Market size and forecast 2023-2028 ($ billion); Exhibits64: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits65: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits66: Market opportunity by Therapy ($ billion); Exhibits67: Data Table on Market opportunity by Therapy ($ billion); Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits69: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits70: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits71: Chart on Geographic comparison; Exhibits72: Data Table on Geographic comparison; Exhibits73: Chart on North America - Market size and forecast 2023-2028 ($ billion); Exhibits74: Data Table on North America - Market size and forecast 2023-2028 ($ billion); Exhibits75: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on Europe - Market size and forecast 2023-2028 ($ billion); Exhibits78: Data Table on Europe - Market size and forecast 2023-2028 ($ billion); Exhibits79: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on Asia - Market size and forecast 2023-2028 ($ billion); Exhibits82: Data Table on Asia - Market size and forecast 2023-2028 ($ billion); Exhibits83: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on US - Market size and forecast 2023-2028 ($ billion); Exhibits90: Data Table on US - Market size and forecast 2023-2028 ($ billion); Exhibits91: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on Germany - Market size and forecast 2023-2028 ($ billion); Exhibits94: Data Table on Germany - Market size and forecast 2023-2028 ($ billion); Exhibits95: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on China - Market size and forecast 2023-2028 ($ billion); Exhibits98: Data Table on China - Market size and forecast 2023-2028 ($ billion); Exhibits99: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits101: Chart on UK - Market size and forecast 2023-2028 ($ billion); Exhibits102: Data Table on UK - Market size and forecast 2023-2028 ($ billion); Exhibits103: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits104: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits105: Chart on Canada - Market size and forecast 2023-2028 ($ billion); Exhibits106: Data Table on Canada - Market size and forecast 2023-2028 ($ billion); Exhibits107: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits108: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits109: Market opportunity By Geographical Landscape ($ billion); Exhibits110: Data Tables on Market opportunity By Geographical Landscape ($ billion); Exhibits111: Impact of drivers and challenges in 2023 and 2028; Exhibits112: Overview on criticality of inputs and factors of differentiation; Exhibits113: Overview on factors of disruption; Exhibits114: Impact of key risks on business; Exhibits115: Companies covered; Exhibits116: Matrix on companies position and classification; Exhibits117: AbbVie Inc. - Overview; Exhibits118: AbbVie Inc. - Product / Service; Exhibits119: AbbVie Inc. - Key news; Exhibits120: AbbVie Inc. - Key offerings; Exhibits121: Aurobindo Pharma Ltd. - Overview; Exhibits122: Aurobindo Pharma Ltd. - Product / Service; Exhibits123: Aurobindo Pharma Ltd. - Key offerings; Exhibits124: Bristol Myers Squibb Co. - Overview; Exhibits125: Bristol Myers Squibb Co. - Product / Service; Exhibits126: Bristol Myers Squibb Co. - Key news; Exhibits127: Bristol Myers Squibb Co. - Key offerings; Exhibits128: Cadila Pharmaceuticals Ltd. - Overview; Exhibits129: Cadila Pharmaceuticals Ltd. - Product / Service; Exhibits130: Cadila Pharmaceuticals Ltd. - Key offerings; Exhibits131: Cipla Inc. - Overview; Exhibits132: Cipla Inc. - Business segments; Exhibits133: Cipla Inc. - Key news; Exhibits134: Cipla Inc. - Key offerings; Exhibits135: Cipla Inc. - Segment focus; Exhibits136: Emcure Pharmaceuticals Ltd. - Overview; Exhibits137: Emcure Pharmaceuticals Ltd. - Product / Service; Exhibits138: Emcure Pharmaceuticals Ltd. - Key offerings; Exhibits139: Gilead Sciences Inc. - Overview; Exhibits140: Gilead Sciences Inc. - Product / Service; Exhibits141: Gilead Sciences Inc. - Key news; Exhibits142: Gilead Sciences Inc. - Key offerings; Exhibits143: GlaxoSmithKline Plc - Overview; Exhibits144: GlaxoSmithKline Plc - Business segments; Exhibits145: GlaxoSmithKline Plc - Key news; Exhibits146: GlaxoSmithKline Plc - Key offerings; Exhibits147: GlaxoSmithKline Plc - Segment focus; Exhibits148: Hetero Labs Ltd. - Overview; Exhibits149: Hetero Labs Ltd. - Product / Service; Exhibits150: Hetero Labs Ltd. - Key offerings; Exhibits151: Johnson and Johnson Services Inc. - Overview; Exhibits152: Johnson and Johnson Services Inc. - Business segments; Exhibits153: Johnson and Johnson Services Inc. - Key news; Exhibits154: Johnson and Johnson Services Inc. - Key offerings; Exhibits155: Johnson and Johnson Services Inc. - Segment focus; Exhibits156: Lupin Ltd. - Overview; Exhibits157: Lupin Ltd. - Product / Service; Exhibits158: Lupin Ltd. - Key news; Exhibits159: Lupin Ltd. - Key offerings; Exhibits160: Merck and Co. Inc. - Overview; Exhibits161: Merck and Co. Inc. - Business segments; Exhibits162: Merck and Co. Inc. - Key news; Exhibits163: Merck and Co. Inc. - Key offerings; Exhibits164: Merck and Co. Inc. - Segment focus; Exhibits165: Sun Pharmaceutical Industries Ltd. - Overview; Exhibits166: Sun Pharmaceutical Industries Ltd. - Product / Service; Exhibits167: Sun Pharmaceutical Industries Ltd. - Key news; Exhibits168: Sun Pharmaceutical Industries Ltd. - Key offerings; Exhibits169: Teva Pharmaceutical Industries Ltd. - Overview; Exhibits170: Teva Pharmaceutical Industries Ltd. - Business segments; Exhibits171: Teva Pharmaceutical Industries Ltd. - Key news; Exhibits172: Teva Pharmaceutical Industries Ltd. - Key offerings; Exhibits173: Teva Pharmaceutical Industries Ltd. - Segment focus; Exhibits174: Viatris Inc. - Overview; Exhibits175: Viatris Inc. - Business segments; Exhibits176: Viatris Inc. - Key news; Exhibits177: Viatris Inc. - Key offerings; Exhibits178: Viatris Inc. - Segment focus; Exhibits179: Inclusions checklist; Exhibits180: Exclusions checklist; Exhibits181: Currency conversion rates for US$; Exhibits182: Research methodology; Exhibits183: Information sources; Exhibits184: Data validation; Exhibits185: Validation techniques employed for market sizing; Exhibits186: Data synthesis; Exhibits187: 360 degree market analysis; Exhibits188: List of abbreviations